[Federal Register Volume 61, Number 217 (Thursday, November 7, 1996)] [Notices] [Page 57693] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-28630] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following National Institute of Allergy and Infectious Diseases Special Emphasis Panel (SEP) meeting: Name of SEP: National Cooperative Drug Discovery Groups for the Treatment of HIV Infection. Date: November 14-15, 1996. Time: 9:00 a.m. Place: Bethesda Holiday Inn, Maryland Room, 8120 Wisconsin Avenue, Bethesda, MD 20814, (301) 652-2000. Contact Person: Dr. Christopher Beisel, Scientific Review Adm., 6003 Executive Boulevard, Solar Bldg., Room 4C03, Bethesda, MD 20892-7610, (301) 402-4596. Purpose/Agenda: To evaluate grant applications. The meeting will be closed in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications and/or proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the applications and/or proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. This notice is being published less than 15 days prior to the meeting due to the urgent need to meet timing limitations imposed by the review and funding cycle. (Catalog of Federal Domestic Assistance Programs Nos. 93.855, Immunology, Allergic and Immunologic Diseases Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health) Dated: October 30, 1996. Paula N. Hayes, Acting Committee Management Officer, NIH. [FR Doc. 96-28630 Filed 11-6-96; 8:45 am] BILLING CODE 4140-01-M